R&D Projects
Introduction of Pipeline
The Daewoong Biologics Indonesia’s R&D center is at the forefront of pioneering research in the pharmaceutical industry. Our primary focus lies in the intricate field of bio-formulation studies, where we are dedicated to enhancing the stability and value of biological products. Through our innovative research approaches and commitment to excellence, we are shaping the future of biopharmaceuticals, ensuring that our developments not only meet but exceed global standards.
Scheme
The scope of the research pipeline is shown as below
- rh-EGF (epidermal growth factor)
- rh-hGH ( human growth hormone)
- rh-BMP2 (Bone morphogenic protein 2)
Products
Easyef
CareTropin
SomaTropin
R&D Projects
| Brand | MOA | Description | Status(Indonesia) | |||||
|---|---|---|---|---|---|---|---|---|
| R | Pre | P1 | P2 | P3 | M | |||
| Easyef Spray | EGF | New Formulation: Integration type for easy use |
||||||
| New Indication : Burn, Traumatic defect, Ulcer |
||||||||
| Caretropin | Sometropin | Biosimilar formulation : Same concentration / dose as a originator |
||||||
| Phase 1 Clinical trial as Biosimilar | ||||||||
| Novosis | rh-BMP 2 | Obtaining supported data using QbD | ||||||
| New Formulation & room temp stabillity date | ||||||||
| Ursa | UDCA | Sourcing UDCA form plant, chicken bile | ||||||
| TBD | rh-TGF beta 3 | New Formulation : Improve stability | ||||||